Your session is about to expire
← Back to Search
Behavioural Intervention
Community Investment for Child Health and Well-being
N/A
Waitlist Available
Led By Atheendar Venkataramani, MD, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
Summary
This trial tests a "big push" intervention in Black neighborhoods to reduce health disparities of children & adults vs White individuals. This includes greening lots, house remediation, tree planting, trash cleanup, public benefits, financial services, & cash assistance.
Who is the study for?
This trial is for Black children aged 3-17 and their caregivers who are knowledgeable about household finances, can text message, and communicate in English. The child must be a permanent resident of the home within the study area. Families planning to move soon or unable to consent fully are excluded.
What is being tested?
The IGNITE for Kids Study tests interventions aimed at improving health and well-being by investing in Black neighborhoods. This includes greening lots, fixing houses, planting trees, cleaning trash, financial counseling, tax help, public benefits access, and emergency cash assistance.
What are the potential side effects?
Since this trial focuses on community investment and financial well-being rather than medical treatments or drugs, it does not have typical side effects. However, there may be unforeseen impacts on community dynamics or individual stress levels.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Child Health Questionnaire Parent Form 28 (CHQ-PF28) Composite Score
Secondary outcome measures
Average sleep duration
Caregiver-reported child health care utilization, emergency room visits
Caregiver-reported child health care utilization, hospitalization
+22 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
At the individual level, participants in the intervention arm will receive place-based and financial well-being interventions.
These will include, at the individual level:
Tax preparation
Access to public benefits
Financial counseling and microgrants
At the neighborhood level:
Abandoned house remediation
Trash cleanup
Vacant lot greening
Tree planting
Group II: Control ArmActive Control1 Intervention
Participants in the control arm will not receive any of the listed interventions
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,027 Previous Clinical Trials
42,885,490 Total Patients Enrolled
Children's Hospital of PhiladelphiaOTHER
712 Previous Clinical Trials
8,589,796 Total Patients Enrolled
Atheendar Venkataramani, MD, PhDPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
378,828 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am comfortable communicating in English.My child is between 3 and 17 years old at the trial's start.My caregiver cannot fully consent or participate in the trial as assessed by the clinical team.I am a parent or caregiver and I am at least 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Control Arm
- Group 2: Intervention Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger